IRLAB to present at Redeye Growth Day 2023 in Stockholm on June 1, 2023
Gothenburg, Sweden, June 1, 2023 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will participate at Redeye Growth Day 2023 on Thursday, June 1, 2023, in Stockholm, Sweden.
[mfn_before_post]
Gothenburg, Sweden, June 1, 2023 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will participate at Redeye Growth Day 2023 on Thursday, June 1, 2023, in Stockholm, Sweden.
Nicholas Waters, EVP and Head of R&D, and Viktor Siewertz, CFO, will participate in the event. The company will be presented at 16:05-16:30 CET on June 1, 2023. This event is held at Haymarket by Scandic, Hötorget 13-15, Stockholm, and is live-streamed.
More information can be found on the event webpage at: https://www.redeye.se/events/871323/redeye-growth-day?tab=abouttheevent.
[mfn_after_post]